A risk model for neutropenic complications was developed and validated in a large prospective cohort of patients who were beginning cancer chemotherapy that may guide the effective and cost-effective use of available supportive care.
Department of Medicine, Duke University, Durham, North Carolina 27710, USA. Gary.Lyman [at] Duke.Edu
Cancer. 2011 May;117(9):1917-27
© Galenicom 1999-2013